FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $203,084 | +24.1% | 43,394 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $163,595 | +19.7% | 43,394 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $136,691 | -77.4% | 43,394 | -57.4% | 0.01% | -80.0% |
| Q3 2022 | $605,000 | +460.2% | 101,931 | +134.9% | 0.02% | +525.0% |
| Q2 2022 | $108,000 | -68.0% | 43,394 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $337,000 | +86.2% | 43,394 | 0.0% | 0.01% | +100.0% |
| Q4 2021 | $181,000 | -47.4% | 43,394 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $344,000 | – | 43,394 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |